In vivo deep network tracing reveals phosphofructokinase-mediated coordination of biosynthetic pathway activity in the myocardium. (January 2022)
- Record Type:
- Journal Article
- Title:
- In vivo deep network tracing reveals phosphofructokinase-mediated coordination of biosynthetic pathway activity in the myocardium. (January 2022)
- Main Title:
- In vivo deep network tracing reveals phosphofructokinase-mediated coordination of biosynthetic pathway activity in the myocardium
- Authors:
- Fulghum, Kyle L.
Audam, Timothy N.
Lorkiewicz, Pawel K.
Zheng, Yuting
Merchant, Michael
Cummins, Timothy D.
Dean, William L.
Cassel, Teresa A.
Fan, Teresa W.M.
Hill, Bradford G. - Abstract:
- Abstract: Glucose metabolism comprises numerous amphibolic metabolites that provide precursors for not only the synthesis of cellular building blocks but also for ATP production. In this study, we tested how phosphofructokinase-1 (PFK1) activity controls the fate of glucose-derived carbon in murine hearts in vivo . PFK1 activity was regulated by cardiac-specific overexpression of kinase- or phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase transgenes in mice (termed Glyco Lo or Glyco Hi mice, respectively). Dietary delivery of 13 C6 -glucose to these mice, followed by deep network metabolic tracing, revealed that low rates of PFK1 activity promote selective routing of glucose-derived carbon to the purine synthesis pathway to form 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). Consistent with a mechanism of physical channeling, we found multimeric protein complexes that contained phosphoribosylaminoimidazole carboxylase (PAICS)—an enzyme important for AICAR biosynthesis, as well as chaperone proteins such as Hsp90 and other metabolic enzymes. We also observed that PFK1 influenced glucose-derived carbon deposition in glycogen, but did not affect hexosamine biosynthetic pathway activity. These studies demonstrate the utility of deep network tracing to identify metabolic channeling and changes in biosynthetic pathway activity in the heart in vivo and present new potential mechanisms by which metabolic branchpoint reactions modulate biosyntheticAbstract: Glucose metabolism comprises numerous amphibolic metabolites that provide precursors for not only the synthesis of cellular building blocks but also for ATP production. In this study, we tested how phosphofructokinase-1 (PFK1) activity controls the fate of glucose-derived carbon in murine hearts in vivo . PFK1 activity was regulated by cardiac-specific overexpression of kinase- or phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase transgenes in mice (termed Glyco Lo or Glyco Hi mice, respectively). Dietary delivery of 13 C6 -glucose to these mice, followed by deep network metabolic tracing, revealed that low rates of PFK1 activity promote selective routing of glucose-derived carbon to the purine synthesis pathway to form 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). Consistent with a mechanism of physical channeling, we found multimeric protein complexes that contained phosphoribosylaminoimidazole carboxylase (PAICS)—an enzyme important for AICAR biosynthesis, as well as chaperone proteins such as Hsp90 and other metabolic enzymes. We also observed that PFK1 influenced glucose-derived carbon deposition in glycogen, but did not affect hexosamine biosynthetic pathway activity. These studies demonstrate the utility of deep network tracing to identify metabolic channeling and changes in biosynthetic pathway activity in the heart in vivo and present new potential mechanisms by which metabolic branchpoint reactions modulate biosynthetic pathways. Graphical abstract: Unlabelled Image Highlights: Deep network tracing is a useful tool for assessing in vivo changes in cardiac biosynthetic pathways. Cardiac phosphofructokinase regulates ancillary biosynthetic pathway activity. Low cardiac phosphofructokinase activity selectively directs glucose-derived carbon toward AICAR biosynthesis. … (more)
- Is Part Of:
- Journal of molecular and cellular cardiology. Volume 162(2022)
- Journal:
- Journal of molecular and cellular cardiology
- Issue:
- Volume 162(2022)
- Issue Display:
- Volume 162, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 162
- Issue:
- 2022
- Issue Sort Value:
- 2022-0162-2022-0000
- Page Start:
- 32
- Page End:
- 42
- Publication Date:
- 2022-01
- Subjects:
- Glycolysis -- Metabolomics -- Stable isotope -- Anabolism -- Metabolons -- Channeling
Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.yjmcc.2021.08.013 ↗
- Languages:
- English
- ISSNs:
- 0022-2828
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25254.xml